Profitability Ratios
| Ratio |
Value |
| GP Margin |
78.3% |
| EBIT Margin |
4.6% |
| EBITDA Margin |
8.9% |
| Operating Margin |
5.5% |
| Pretax Margin |
4.5% |
| Cont. Ops Margin |
1.2% |
| Net Margin |
1.2% |
| Bottom Line Margin |
1.2% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.24 |
| Quick Ratio |
1.45 |
| Solvency Ratio |
0.322 |
| Cash Ratio |
1.23 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.46 |
| Forward PEG |
-0.46 |
| Price/Book |
0.68 |
| Price/Sales |
0.39 |
| Price/FCF |
42.35 |
| Price/Op Cash Flow |
16.16 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0188 |
| Debt/Equity |
0.0263 |
| Debt/Capital |
0.0256 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.39 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
6.18 |
| Operating Cash Flow Ratio |
0.174 |
| Operating Cash Flow/Sales |
2.4% |
| Free Cash Flow/Operating Cash Flow |
38.1% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
3.50 |
| Interest Coverage |
60.4062 |
| Short-Term Operating Cash Flow Coverage |
1.60 |
| Operating Cash Flow Coverage |
1.60 |
| Capital Expenditure Coverage |
1.62 |
| Dividend + Capital Expenditure Coverage |
1.62 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
49.81 |
| EPS |
0.579 |
| Debt/Share |
0.7991 |
| Cash/Share |
8.53 |
| Book Value/Share |
31.56 |
| Tangible BV/Share |
16.97 |
| Equity/Share |
28.70 |
| Operating Cash Flow/Share |
1.203 |
| Capital Expenditure/Share |
0.744 |
| FCF/Share |
0.459 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.259 |
| Earnings Before Tax/EBIT |
0.816 |
| Price/Fair Value |
0.68 |
| Debt/Market Cap |
0.0388 |
| Effective Tax Rate |
72.4% |
| Enterprise Value Multiple |
2.64 |
USNA - USANA Health Sciences, Inc.